Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-01 @ 5:16 PM
Study NCT ID:
NCT00592969
Status:
COMPLETED
Last Update Posted:
2017-02-24
First Post:
2008-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12-03
Start Date Type:
ACTUAL
Primary Completion Date:
2004-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-11-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-02
First Submit QC Date:
None
Study First Post Date:
2008-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-22
Last Update Post Date:
2017-02-24
Last Update Post Date Type:
ACTUAL